Melissa A. Ashlock

4.8k total citations · 1 hit paper
28 papers, 1.6k citations indexed

About

Melissa A. Ashlock is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Melissa A. Ashlock has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Melissa A. Ashlock's work include Cystic Fibrosis Research Advances (13 papers), Neonatal Respiratory Health Research (4 papers) and CRISPR and Genetic Engineering (4 papers). Melissa A. Ashlock is often cited by papers focused on Cystic Fibrosis Research Advances (13 papers), Neonatal Respiratory Health Research (4 papers) and CRISPR and Genetic Engineering (4 papers). Melissa A. Ashlock collaborates with scholars based in United States, France and Hong Kong. Melissa A. Ashlock's co-authors include Eric R. Olson, Russell F. Warren, Steven P. Arnoczky, Fredrick Van Goor, Jeffrey J. Wine, Peter D. J. Grootenhuis, Paul A. Negulescu, Bill Burton, Sabine Hadidaꝉ and Jeffrey H. Stack and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Melissa A. Ashlock

27 papers receiving 1.6k citations

Hit Papers

Correction of the F508del-CFTR protein processing defect ... 2011 2026 2016 2021 2011 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
    2011 831 citations Fredrick Van Goor, Sabine Hadidaꝉ et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melissa A. Ashlock United States 13 1.0k 494 263 154 139 28 1.6k
Joann M. Hettasch United States 12 363 0.4× 219 0.4× 47 0.2× 83 0.5× 13 0.1× 12 753
B Schneider Germany 15 142 0.1× 191 0.4× 293 1.1× 26 0.2× 21 0.2× 29 1.0k
Lan Tang China 17 81 0.1× 650 1.3× 141 0.5× 76 0.5× 21 0.2× 32 1.0k
Marina Mazur United States 18 922 0.9× 344 0.7× 38 0.1× 191 1.2× 32 0.2× 35 1.3k
Kohei Miyata Japan 18 49 0.0× 603 1.2× 113 0.4× 104 0.7× 26 0.2× 75 1.2k
Lingyun Tang China 16 217 0.2× 304 0.6× 80 0.3× 52 0.3× 12 0.1× 47 925
Neil Ahluwalia United States 17 661 0.7× 220 0.4× 136 0.5× 117 0.8× 49 0.4× 28 1.2k
Kuang‐Hsiang Chuang United States 14 278 0.3× 424 0.9× 65 0.2× 44 0.3× 10 0.1× 15 1.2k
Soon Keng Cheong Malaysia 18 169 0.2× 418 0.8× 115 0.4× 88 0.6× 10 0.1× 91 1.0k

Countries citing papers authored by Melissa A. Ashlock

Since Specialization
Citations

This map shows the geographic impact of Melissa A. Ashlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa A. Ashlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa A. Ashlock more than expected).

Fields of papers citing papers by Melissa A. Ashlock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa A. Ashlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa A. Ashlock. The network helps show where Melissa A. Ashlock may publish in the future.

Co-authorship network of co-authors of Melissa A. Ashlock

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa A. Ashlock. A scholar is included among the top collaborators of Melissa A. Ashlock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa A. Ashlock. Melissa A. Ashlock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Jie, Feng Wang, Zhiwen Xu, et al.. (2014). Secreted Histidyl-tRNA Synthetase Splice Variants Elaborate Major Epitopes for Autoantibodies in Inflammatory Myositis. Journal of Biological Chemistry. 289(28). 19269–19275. 42 indexed citations
3.
Accurso, Frank J., Fredrick Van Goor, Jiuhong Zha, et al.. (2013). Sweat chloride as a biomarker of CFTR activity: Proof of concept and ivacaftor clinical trial data. Journal of Cystic Fibrosis. 13(2). 139–147. 111 indexed citations
4.
Clancy, John, Rhonda D. Szczesniak, Melissa A. Ashlock, et al.. (2013). Multicenter Intestinal Current Measurements in Rectal Biopsies from CF and Non-CF Subjects to Monitor CFTR Function. PLoS ONE. 8(9). e73905–e73905. 47 indexed citations
5.
Goor, Fredrick Van, Sabine Hadidaꝉ, Peter D. J. Grootenhuis, et al.. (2011). Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proceedings of the National Academy of Sciences. 108(46). 18843–18848. 831 indexed citations breakdown →
6.
Rowe, Steven M., Frank J. Accurso, Jordan Dunitz, et al.. (2010). Improvement in ion transport biomarkers and spirometry with the investigational CFTR potentiator VX-770 in subjects with cystic fibrosis and the G551D-CFTR mutation. Paediatric Respiratory Reviews. 11. S99–S99. 1 indexed citations
7.
Solomon, George M., Michael W. Konstan, Michael Wilschanski, et al.. (2010). An International Randomized Multicenter Comparison of Nasal Potential Difference Techniques. CHEST Journal. 138(4). 919–928. 38 indexed citations
8.
9.
Ashlock, Melissa A. & Eric R. Olson. (2010). Therapeutics Development for Cystic Fibrosis: A Successful Model for a Multisystem Genetic Disease. Annual Review of Medicine. 62(1). 107–125. 36 indexed citations
10.
Rowe, Steven M., Fredrick Van Goor, Carlos A. Ordóñez, et al.. (2010). Parallel effects of VX-770 on transepithelial potential difference in vitro and in vivo. Journal of Cystic Fibrosis. 9. S20–S20. 8 indexed citations
11.
Ashlock, Melissa A., Robert J. Beall, N. Hamblett, et al.. (2009). A Pipeline of Therapies for Cystic Fibrosis. Seminars in Respiratory and Critical Care Medicine. 30(5). 611–626. 20 indexed citations
12.
Marshall, Bruce C., Leslie Hazle, Melissa A. Ashlock, et al.. (2009). Cystic Fibrosis Foundation: Achieving the Mission. Respiratory Care. 54(6). 788–795. 1 indexed citations
13.
Goor, Fredrick Van, Bill Burton, Sabine Hadidaꝉ, et al.. (2009). Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Journal of Cystic Fibrosis. 8. S17–S17. 41 indexed citations
14.
Marshall, Bruce C., Leslie Hazle, Melissa A. Ashlock, et al.. (2009). Cystic Fibrosis Foundation: Achieving the Mission. Respiratory Care. 54(6). 788–795. 22 indexed citations
15.
Accurso, Frank J., Steven M. Rowe, Peter R. Durie, et al.. (2009). Final results of a 14- and 28-day study of VX-770 in subjects with CF. Journal of Cystic Fibrosis. 8. S25–S25. 3 indexed citations
16.
Mogayzel, Peter J. & Melissa A. Ashlock. (2000). CFTR Intron 1 Increases Luciferase Expression Driven by CFTR 5′-Flanking DNA in a Yeast Artificial Chromosome. Genomics. 64(2). 211–215. 12 indexed citations
17.
Stephan, Dietrich A., Yidong Chen, Yuan Jiang, et al.. (2000). Positional Cloning Utilizing Genomic DNA Microarrays: The Niemann–Pick Type C Gene as a Model System. Molecular Genetics and Metabolism. 70(1). 10–18. 9 indexed citations
18.
Gu, Jessie, Xin‐Yuan Guan, & Melissa A. Ashlock. (1999). Isolation of Human Transcripts Expressed in Hamster Cells from YACs by cDNA Representational Difference Analysis. Genome Research. 9(2). 182–188. 4 indexed citations
19.
Mansoura, Monique K., Joachim Biwersi, Melissa A. Ashlock, & A. S. Verkman. (1999). Fluorescent Chloride Indicators to Assess the Efficacy of CFTR cDNA Delivery. Human Gene Therapy. 10(6). 861–875. 31 indexed citations
20.
Chen, Min, et al.. (1997). Transient gene expression from yeast artificial chromosome DNA in mammalian cells is enhanced by adenovirus. Nucleic Acids Research. 25(21). 4416–4418. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joann M. Hettasch Breakdown of academic impact, for papers by B Schneider Breakdown of academic impact, for papers by Lan Tang Breakdown of academic impact, for papers by Marina Mazur Breakdown of academic impact, for papers by Kohei Miyata Breakdown of academic impact, for papers by Lingyun Tang Breakdown of academic impact, for papers by Neil Ahluwalia Breakdown of academic impact, for papers by Kuang‐Hsiang Chuang Breakdown of academic impact, for papers by Soon Keng Cheong
Rankless by CCL
2026